close-icon

Download helpful resources

  • RELISTOR Patient Brochure

    Brochure for your patients to learn more about RELISTOR and OIC.

    Brochure for your patients to learn more about RELISTOR and OIC.
    Download

  • Doctor Discussion Guide

    Tool to help patients evaluate and talk about their symptoms.

    Tool to help patients evaluate and talk about their symptoms.
    Download

  • Guide to Taking RELISTOR

    Helps patients learn how to take RELISTOR tablets.

    Helps patients learn how to take RELISTOR tablets.
    Download

  • RELISTOR Savings Card

    Helps eligible patients save on their prescription.

    Helps eligible patients save on their prescription.
    Download

  • RELISTOR Dosing Guide

    Tool for more dosing information for RELISTOR tablets and injection.

    Tool for more dosing information for RELISTOR tablets and injection.
    Download

  • Opioid-Induced Constipation Screener

    Tool to help identify and evaluate OIC symptoms.

    Tool to help identify and evaluate OIC symptoms.
    Download

  • Journal of Emergency Medicine Reprint

    Learn about the impact of RELISTOR in the emergency department.

    Learn about the impact of RELISTOR in the emergency department.
    See full Prescribing Information
    Download

  • INTENDED FOR USE ONLY WITH POPULATION-BASED HEALTHCARE DECISION MAKERS.

    Advances in Therapy Reprint

    Article containing healthcare economic data for use of RELISTOR in the emergency department.

    Article containing healthcare economic data for use of RELISTOR in the emergency department.
    See full Prescribing Information
    Download
See More
IMPORTANT SAFETY INFORMATION
  • RELISTOR tablets and injection are contraindicated in patients with known or suspected mechanical gastrointestinal obstruction and patients at increased risk of recurrent obstruction, due to the potential for gastrointestinal perforation.
INDICATIONS
  • RELISTOR® is an opioid antagonist. RELISTOR tablets and RELISTOR injection are indicated for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.
IMPORTANT SAFETY INFORMATION
  • RELISTOR tablets and injection are contraindicated in patients with known or suspected mechanical gastrointestinal obstruction and patients at increased risk of recurrent obstruction, due to the potential for gastrointestinal perforation.